SIGA Technologies (SIGA)

• Market cap: $643M
• 1 day: 0.67%
• 5 days: 4.78%
• 1 month: 5.65%
• 3 months: 38.15%
• 6 months: 59.5%
• Year to date: 43.91%
• 1 year: 12.39%
• 5 years: 26.3%
• 10 years: 47.7%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Employees: 45

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

248% more call options, than puts

Call options by funds: $763K | Put options by funds: $219K

55% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 22

26% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 50

17% more capital invested

Capital invested by funds: $192M [Q1] → $225M (+$32.4M) [Q2]

6% more funds holding

Funds holding: 166 [Q1] → 176 (+10) [Q2]

0.88% less ownership

Funds ownership: 49.12% [Q1] → 48.23% (-0.88%) [Q2]